PTI-428/PTI-808/PTI-801

N/A

Report date: 2024/06/24 16:23:09

Base Information

Drug NamePTI-428/PTI-808/PTI-801
Drug Alias NamePTI-801+PTI-428+PTI-808PTI-801/PTI-428/PTI-808PTI-808/PTI-801/PTI-428Dirocaftor/Posenacaftor/NesolicaftorDiponecaftor +[7] 
ClassificationSmall molecules
Mechanisms of ActionCystic fibrosis transmembrane conductance regulator modulators
TargetsCystic fibrosis transmembrane conductance regulator
Therapy Area/IndicationsCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes NesolicaftorPTI-801Dirocaftor
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesProteostasis Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesProteostasis Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCystic Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A